Dong H, Kerr T Joint trajectories of heroin use and treatment utilisation: who will benefit in the long term? EClinicalMedicine, 2019. PubMed

Collins AB, Boyd J, Cooper HLF, McNeil R The intersectional risk environment of people who use drugs Soc Sci Med, 2019. PubMed

Brar R, Sutherland C, Nolan S Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder BMJ Case Rep, 2019. PubMed

Socías ME, Ti L, Wood E, Nosova E, Hull M, Hayashi K, DeBeck K, Milloy MJ Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting Liver Int, 2019. PubMed

Amram O, Socías ME, Nosova E, Kerr T, Wood E, DeBeck K, Hayashi K, Fairbairn N, Montaner J, Milloy MJ Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: a spatial analysis Spat Spatiotemporal Epidemiol, 2019. PubMed

Beaulieu T, Nolan S, Ti L Hepatitis C treatment among incarcerated individuals in Canada and strategies to prevent reinfection in the postrelease period J Epidemiol Community Health, 2019. PubMed

Barker B, Sedgemore K, Tourangeau M, Lagimodiere L, Milloy J, Dong H, Hayashi K, Shoveller J, Kerr T, DeBeck K Intergenerational trauma: the relationship between residential schools and the child welfare system among young people who use drugs in Vancouver, Canada J Adolesc Health, 2019. PubMed

Kim B, Nolan S, Beaulieu T, Shalansky S, Ti L Inappropriate opioid prescribing practices: a narrative review Am J Health Syst Pharm, 2019. PubMed

Clark J, Fairbairn N, Nolan S, Li T, Wu A, Barrios R, Montaner J, Ti L; STOP HIV/AIDS in BC Study Group Prescription of high-dose opioids among people living with HIV in British Columbia, Canada AIDS Behav, 2019. PubMed

Ahamad K, Dong H, Johnson C, Hayashi K, DeBeck K, Milloy MJ, Wood E Factors associated with willingness to wear an electronic overdose detection device Addict Sci Clin Pract, 2019. PubMed